Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE000A12ULL2
Mon, 15.08.2022       Aladdin Healthcare Technologies SE
DE000A12ULL2

Berlin, Germany, 15 August 2022 - Aladdin Healthcare Technologies SE ("the Company") announces that the German Federal Financial Supervisory Authority (BaFin) has informed the Company that it intends to impose fines in the total of approximately EUR 155,000 against the Company. Subject of the fines are late and incomplete financial and half-yearly  [ … ]
Technical analysis
To the publication
Mon, 15.08.2022       Aladdin Healthcare Technologies SE
DE000A12ULL2

Berlin, Germany, 15 August 2022 - Aladdin Healthcare Technologies SE ("the Company") announces that the German Federal Financial Supervisory Authority (BaFin) has informed the Company that it intends to impose fines in the total of approximately EUR 155,000 against the Company. Subject of the fines are late and incomplete financial and half-yearly  [ … ]
Technical analysis
To the publication
Wed, 24.11.2021       Aladdin Healthcare Technologies SE
DE000A12ULL2

Aladdin Healthcare Technologies SE approved for Listing on OTCQB in the USA BERLIN/LONDON November 24, 2021 - Aladdin Healthcare Technologies SE ("Aladdin", ISIN: DE000A12ULL2), a leading developer of Artificial Intelligence (AI) based healthcare diagnostics and drug discovery applications, announces that it has gained approval from OTC Markets G [ … ]
Technical analysis
To the publication
Wed, 14.07.2021       Aladdin Healthcare Technologies SE
DE000A12ULL2

Aladdin Healthcare Technologies with new research findings on COVID-19 diagnosis BERLIN/LONDON, July 14, 2021 - Aladdin Healthcare Technologies SE ("Aladdin", ISIN: DE000A12ULL2), a leading developer of Artificial Intelligence (AI) based healthcare diagnostics and drug discovery applications, is one of the co-authors of a high-impact review on th [ … ]
Technical analysis
To the publication
Tue, 18.05.2021       Aladdin Healthcare Technologies SE
DE000A12ULL2

Aladdin Healthcare Technologies SE reports the sale of software and intellectual property BERLIN/LONDON, 18 May 2021 - Aladdin Healthcare Technologies SE (the "Company") reports that its 100% subsidiary Aladdin Healthcare Technologies Ltd ("Aladdin Ltd") has today completed the sale of specific software and intellectual property to a customer based [ … ]
Technical analysis
To the publication
Fri, 22.01.2021       Aladdin Healthcare Technologies SE
DE000A12ULL2

Aladdin Healthcare Technologies signs Agreement to build proprietary Genomic Data Blockchain Platform with Zero Knowledge Proof BERLIN/LONDON January 22, 2021 - Aladdin Healthcare Technologies SE ("Aladdin", ISIN: DE000A12ULL2), a leading developer of Artificial Intelligence (AI) based healthcare diagnostics and drug discovery applications, has si [ … ]
Technical analysis
To the publication
Tue, 08.12.2020       Aladdin Healthcare Technologies SE
DE000A12ULL2

Aladdin Healthcare Technologies SE reports preliminary figures for financial year 2019 and readjustment of the 2018 financial year figures Aladdin Healthcare Technologies SE (the "Company") reports that in the course of the preparation of its consolidated annual financial statements under IFRS for the financial year 2019, losses in the amount of EU [ … ]
Technical analysis
To the publication
Mon, 09.11.2020       Aladdin Healthcare Technologies SE
DE000A12ULL2

Aladdin Healthcare Technologies discovers anti-osteoporosis nanomolar activity leads from natural compounds dataset with its Deep Learning Algorithms for drug discovery, validated by leading scientific publication "European Journal of Medicinal Chemistry" - Innovative deep learning algorithms allow a successful virtual screening of anti-osteoporos [ … ]
Technical analysis
To the publication
Thu, 08.10.2020       Aladdin Healthcare Technologies SE
DE000A12ULL2

Aladdin Healthcare Technologies completes AI-driven Drug Discovery Platform (AIDD) for Commercial Use in Drug Development   - Aladdin has successfully released its proprietary AI Drug Discovery Platform to accelerate the drug development process. - The automated machine learning platform pipeline covers main stages of early drug discovery: Virtu [ … ]
Technical analysis
To the publication
Thu, 24.09.2020       Aladdin Healthcare Technologies SE
DE000A12ULL2

Aladdin Healthcare Technologies will obtain an equity stake in public spinoff No-Age Biotech Inc. at TSX, aimed to combat age-related diseases   - Aladdin has agreed to obtain a 25% equity stake in No-Age Biotech Inc., publicly traded spinoff at TSX, in late 2020. - No-Age Biotech will be focused on the development of therapeutics to combat age-r [ … ]
Technical analysis
To the publication

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Thursday, 04.07.2024, Calendar Week 27, 186th day of the year, 180 days remaining until EoY.